Q3 FY2025 · Presentation
Topline results Phase 3 RISE UP in sickle cell disease · 37 pages
Read Agios Pharmaceuticals, Inc.'s results firsthand
Preview the first 2 pages of this presentation
Create a free account to start reading
Full documents are included with Professional